B-Raf | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

21,783 results for “B-Raf”

Trials

View all 12177 →

Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease

20 participants · First posted Nov 2, 2012

Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation

19 participants · First posted Jan 23, 2012

Interest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot Study

5 participants · First posted Jan 16, 2014

Drugs

View all 2396 →

Anti-B-RAF(Janssen Diagnostics)

B-Raf V600E inhibitors (melanoma)

B-Raf/EGFR dual inhibitors (cancer)

Organizations

View all 3139 →

AB&B BIO-TECH-B

B R B Software Systems Inc

United States

VIGONVITA-B

News

View all 4071 →

Lutris Pharma to Present Phase 2 Results of Novel B-Raf Inhibitor for EGFR Inhibitor-Induced Skin Rash at AACR 2025

Delhi High Court Sets Aside Refusal of Array BioPharma's Cancer Drug Combination Patent, Orders Fresh Review

Bristol Myers Squibb Initiates Two Phase I Trials Testing Novel Therapies for Advanced Solid Tumors and Relapsed/Refractory Lymphomas

Page 1 of 2179